Statins, central blood pressure, and blood pressure amplification

Circulation

Volumn 119, Issue 1, 2009, Pages 9-12

  Safar, Michel E ^a,c   Protogerou, Athanase D ^b   Blacher, Jacques ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; INDAPAMIDE PLUS PERINDOPRIL; PERINDOPRIL; PLACEBO;

ATHEROSCLEROSIS; CLINICAL TRIAL; EDITORIAL; HEART RATE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MEDICAL INSTRUMENTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ATHEROSCLEROSIS; BLOOD PRESSURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; RISK FACTORS;

EID: 59049099133     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.824532     Document Type: Editorial

References (20)

1. Nichols WW, O'Rourke MF. McDonald's Blood flow in Arteries: Theoretical, Experimental and Clinical Principles. 5th ed. London, UK: Edward Arnold; 2005:165-191, 174-177, 201, 360-363.
2. Safar M, Blacher J, Pannier B, Marchais S, Guyonvarc'h PM, London G. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735-738.
3. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197-203.
4. Jankowski P, Kawecka-Jaszcz K, Czarnecka D, Brzozowska-Kiszka M, Styczkiewicz K, Loster M, Kloch-Badelek M, Wlinski J, Curylo DM, Dudek D; on behalf of the aortic blood pressure and survival study group. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension. 2008;51:848-855.
5. London GM, Asmar RG, O'Rourke MF, Safar ME; REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99.
6. Williams B, Lacy PS, Thorn SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-1225.
7. Williams B, Lacy PS, Cruickshank JK, Collier D, Hughes AD, Stanton A, Thorn S, Thurston H, for the CAFE and ASCOT Investigators. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid Lowering Arm (CAFE-LLA) study. Circulation. 2008;119:53-61.
8. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, Mclnnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet. 2005;366:895-906.
9. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, Mclnnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid lowering Arm (ASCOT-LLA): a multicenter randomised controlled trial. Lancet. 2003; 361:1149-1158.
10. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and pulse wave velocity. The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46:1753-1760.
11. Vergnaud AC, Protogerou AD, Blacher J, Safar ME. From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy. J Hypertens. 2008;26:138-144.
12. Safar ME, Blacher J, Protogerou A, Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. J Hypertens. 2008;26:130-137.
13. Safar ME, Levy BI, Struijker-Boudier HJ. Current perspectives on arterial stiffness and pulse pressure in hypertension and CV diseases. Circulation. 2003;107:2864-2869.
14. de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME; REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623-1630.
15. Wilkinson IB, Cockcroft JR. Cholesterol, lipids and arterial stiffness. In: ME Safar ME and Frohlich ED, eds. Advances in Cardiology Vol. 44: Atherosclerosis, Large Arteries and CV Risk. S. Basel, Switzerland: Karger AG, 2007:261-277.
16. Colomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH. Reduction in blood pressure with statins: results from the UCSD statin study, a randomized trial. Arch Intern Med. 2008;168:721-727.
17. Strazzullo P, Kerry SM, Barbato A, Versiero M, Elia LD, Cappucio FP. Do statins reduce blood pressure? A meta-analysis of randomized controlled trials. Hypertension. 2007;49:792-798.
18. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomized trials of statins. Lancet. 2005; 366:1267-1278.
19. Farrar DJ, Green HD, Wagner WD, Bond G. Reduction in pulse wave velocity and improvement of aortic distensibility accompanying regression of atherosclerosis in the rhesus monkey. Circ Res. 1980;47: 425-432.
20. Raison J, Rudnichi A, Safar ME. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolemia: a preliminary study. J Hum Hypertens. 2002;16:705-710.